Trending: Former BioNTech VP Katalin Karikó and Drew Weissman Win Nobel Prize for mRNA Work
02 Outubro 2023 - 4:11PM
Dow Jones News
1440 ET -- BioNTech is one of the most mentioned companies in
the U.S. across all news items in the last 12 hours, according to
Factiva data. Katalin Karikó, a molecular biologist and former
BioNTech senior vice president, and immunologist Dr. Drew Weissman
won the Nobel Prize in medicine for their work on the mRNA
technology used in the BioNTech/Pfizer and Moderna Covid-19
vaccines. The Nobel committee said they "contributed to the
unprecedented rate of vaccine development during one of the
greatest threats to human health in modern times." Dow Jones &
Co. owns Factiva. (josh.beckerman@wsj.com)
(END) Dow Jones Newswires
October 02, 2023 14:56 ET (18:56 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
BioNTech (NASDAQ:BNTX)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
BioNTech (NASDAQ:BNTX)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024